axicabtagene ciloleucel,fludarabine
gilead,daiichi sankyo,Bayer
['axi-cel', 'fludarabine']
important data showing association of fludarabine pk-pd with axi-cel outcomes in lbcl. under exposure increases risk of relapse and overexposure increases risk of toxicity. #ash22